Cefdinir Power: The Ultimate Guide to Dinar Capsules for Bacterial Infections
Composition:
Each Dinar capsule contains 300 mg of cefdinir.
Properties:
Dinar capsules contain the active ingredient cefdinir, an extended-spectrum, semisynthetic third-generation cephalosporin, for oral administration. Cefdinir's bactericidal activity results from inhibiting cell wall synthesis. It has been shown to be active against most strains of microorganisms:
- Aerobic Gram-positive microorganisms: Staphylococcus aureus (including B-lactamase-producing strain), Streptococcus pneumoniae, and Streptococcus pyogenes.
- Aerobic Gram-negative microorganisms: Haemophilus influenzae, Haemophilus parainfluenzae, and Moraxella catarrhalis (including B-lactamase-producing strain).
Indications:
- Community-acquired pneumonia.
- Acute exacerbations of chronic bronchitis.
- Acute maxillary sinusitis.
- Pharyngitis/Tonsillitis caused by Streptococcus pyogenes.
- Uncomplicated skin and skin structure infections caused by Staphylococcus aureus and Streptococcus pyogenes.
Dosage Administration:
Adults:
- Mild to moderate infections: 300 mg twice daily or 600 mg once daily for 10 days.
- Dosing adjustment in renal impairment: CLcr<30 ml/minute: 300 mg once daily.
- For patients undergoing haemodialysis, the recommended initial dose is 300 mg every other day. At the end of each haemodialysis session, 300 mg should be administered.
Contraindications:
Dinar capsules are contraindicated in patients with a known allergy to the cephalosporin class of antibiotics.
Packing:
Each box contains 10 capsules in 1 strip.
Dinar is a product manufactured by Adwia Pharmaceuticals Industries. Adwia is a leading Egyptian company founded in 1984 with a mission to bring the latest technologies and the highest available know-how to the market. They are committed to innovation and care and have a proven track record of success. For more information about Adwia Pharmaceuticals Industries, please visit their website or contact them directly.
Comments
Post a Comment